I-Mab's Antibody for Severe COVID-19 Looks Good in Interim Analysis

Retrieved on: 2021-08-11 18:22:30

Tags for this article:

Medical specialties

Health

Immunology

Monoclonal antibodies

Cytokine storm

Cytokine release syndrome

COVID-19

Lenzilumab

Cytokine

COVID-19 drug development

Bamlanivimab

United States

I-Mab

Click the tags to see associated articles and topics

I-Mab's Antibody for Severe COVID-19 Looks Good in Interim Analysis. View article details on hiswai:

Excerpt

I-Mab announced positive interim data from its U.S. Phase II/III clinical trial of plonmarlimab for treatment of cytokine release syndrome (CRS) in severe ...

Article found on: www.biospace.com

View Original Article